These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
The facility features 2,176 high-performance GPUs across the US and Europe
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The planned facility, to be built at Samsung’s Bio Campus II, is set to become a launchpad for up to 30 emerging biotech firms
The initiative comes through a collaboration with Asia’s oldest latex condom manufacturer
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
COVIRIX Medical says its broad-spectrum antiviral portfolio has already shown positive virology results against key pandemic threats
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The acquisition of Biocare enhances Agilent’s pathology portfolio and reflects our strategy to drive long-term growth
Subscribe To Our Newsletter & Stay Updated
